Home
Metagenomi

Metagenomi Market Share Analysis for November 2025

Metagenomi is transforming novel gene editing tools, mined from the world’s natural microbial environment, into life-saving genetic medicines.

Health > Biotechnology and Pharmaceuticals

Domainmetagenomi.co

Year Founded2018

Employees51 - 200

Annual Revenue$25M - $50M

Metagenomi

Metagenomi (including company regionals)

metagenomi.co

See more website traffic and engagement information

Metagenomi Revenue up to November 2025 is 25M - 50M

revenue generated by Metagenomi top domains

Metagenomi top domains revenue over 3 years

Revenue for Metagenomi top domains

metagenomi.co25M - 50M

See more with Sales Intelligence

Total visits to Metagenomi's top domains

Understand Metagenomi market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

metagenomi.co5.4K

See more with Sales Intelligence

Avg. visit duration in Metagenomi's top domains

Analyze Metagenomi engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

metagenomi.co00:01:12

See more with Sales Intelligence

Avg. pageviews on Metagenomi's top domains

See how Metagenomi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

metagenomi.co2.58

See more with Sales Intelligence

Metagenomi top competitors by domain

Top similar sites in November 2025, ranked by their affinity

rxwellness.netCompany NameRxWellness Spine & HealthEmployees51 - 200HQUnited States, Virginia, HerndonAnnual revenue$5M - $10MTotal visits14.5KHealth > Alternative and Natural Medicine

Top technologies used by Metagenomi

These are the website technologies, by industry, used by Metagenomi top domains

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

More Technologies

5

See all

News & Signals from Metagenomi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMetagenomi, Inc. partners with Ionis Pharmaceuticals, Inc..Going forward, Metagenomi will focus on its "later-stage" preclinical pipeline, including a gene-editing program for hemophilia A and cardiometabolic prospects involved in a collaboration with Ionis Pharmaceuticals.

NewsMetagenomi, Inc. attended event 28th Annual Meeting on May 14th '25.EMERYVILLE, Calif., May 14, 2025 (GLOBE NEWSWIRE) - Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced the presentation of three abstracts at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, taking place from May 13 - 17, 2025, in New Orleans, Louisiana.

NewsMetagenomi, Inc. attends event Business Updates and Full Year 2024 Financial Results.Metagenomi reports Business Updates and Full Year 2024 Financial Results.